Kepler Cheuvreux re-initiated coverage of Aperam (APEMY) with a Buy rating and EUR 31.10 price target The company has become “much stronger” through its diversification efforts, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APEMY:
- Aperam price target lowered to EUR 29.60 from EUR 30.10 at Morgan Stanley
- Aperam Reports Challenging Q1 2025 Financial Results
- Aperam’s Strategic Growth and Sustainability Focus in Q1 2025 Earnings Call
- APEMY Upcoming Earnings Report: What to Expect?
- Aperam price target lowered to EUR 38 from EUR 40 at Deutsche Bank